查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球血管造影套件市場 - 2022-2029
市場調查報告書
商品編碼
1129252

全球血管造影套件市場 - 2022-2029

Global Angio Suites Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

介入腫瘤學中精密 CT 系統的技術進步預計將推動市場增長。

結合標準血管造影和橫截面圖像的組合血管造影 CT (AngioCT) 系統極大地受益於介入放射學。平板血管造影系統中的錐形束 CT (CBCT) 技術長期以來一直被用作介入手術期間的輔助橫斷面成像工具，但血管 CT 系統在卓越的軟組織成像方面的獨特優勢和由於其對比分辨率和易於操作，人們對其在介入腫瘤學中的應用重新產生了興趣。由於工作流程的改進提高了價格和易用性，Angio-CT 系統已成為獨立配備 CBCT 的平板血管造影系統的競爭替代品。此外，通過將 CT 掃描儀的橫截面圖像與血管造影的透視圖像相結合，我們可以更準確地規劃腫瘤干預措施，將多種治療結合在一個地方，跟蹤術中治療反應，減少並發症，改善治療效果。因此，從上述陳述來看，預計市場將在預測期內受到驅動。

限制

在預測期內，與安裝血管造影套件相關的高成本、熟練使用血管造影套件的人員短缺、重建成像診斷設備的使用增加以及輻射暴露的高風險預計將增加。這是阻礙市場的因素之一。

行業分析

血管造影套件市場根據波特五力、供應鏈分析、報銷方案、產品創新和定價分析等各種行業因素對市場進行了深入分析。

COVID-19 影響分析

COVID-19 大流行對醫療保健系統和市場產生了適度影響。在冠狀病毒活躍的大流行期間，心髒病和其他慢性病的病例有所增加。對血管造影套件的需求猛增，因為它是一種最先進的設備，用於可視化人體血管，尤其是動脈的內部，以進行準確和有效的診斷。隨著 COVID-19 的激增，心髒病患者的激增增加了對現代血管造影套件的需求。美國疾病控制和預防中心正在推遲選擇性心臟手術，例如冠狀動脈造影和經皮冠狀動脈介入治療以治療穩定的冠狀動脈疾病，節省個人防護設備和病床等資源，以確保 COVID-19 患者的安全。我建議您服用照顧它。在 COVID 流行的早期階段，預計美國心導管實驗室的 STEMI 激活減少 38%，與西班牙 40% 的減少相當。

此外，大流行還將擾亂供應鍊和流程。許多公司轉移到其他地區以確保產品可用性並保護其供應鏈。因此，從上面這句話來看，市場受到了影響，預計隨著經濟活動的恢復，市場將迅速獲得牽引力。

全球血管造影套件市場報告提供大約 45 多個市場數據表、40 多個圖表和 180 頁內容。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 預計介入腫瘤學中精密 CT 系統的技術進步將推動市場增長。
    • 限制因素
      • 與安裝血管造影套件相關的高成本預計會阻礙市場增長。
    • 市場機會
    • 影響分析

第五章行業分析

  • 供應鏈分析
  • 定價分析
  • 未滿足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 單機
  • 雙翼飛機

第 8 章按設備

  • X 射線發生器
  • C型臂
  • X 射線探測器
  • 手術台
  • 其他

第 9 章。按應用程序

  • 血管成形術
  • 支架治療
  • 閉塞性搭橋手術
  • 血管內治療
  • 椎板成形術
  • 骨髓造影劑
  • 動靜脈畸形手術
  • 冠狀動脈造影
  • 其他

第 10 章，最終用戶

  • 醫院
  • 診斷中心
  • 心血管導管實驗室
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準
  • 值得關注的重點公司列表

第 13 章公司簡介

  • 西門子醫療保健有限公司
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Koninklijke Philips N.V.
  • GE Healthcare
  • Carestream Health
  • Canon Medical Systems Corporation
  • Shimadzu Corp
  • 3D Systems
  • IMRIS

第 14 章全球血管造影套件市場 - DataM

簡介目錄
Product Code: DMMI5803

Market Overview

The Angio Suites Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 5% during the forecast period (2022-2029).

Angio suites are well-resourced, multipurpose areas used to carry out interventional vascular procedures. These facilities carry out several medical treatments, including minimally invasive endovascular surgery, ischemic stroke treatment, myelograms, aortic dissection, ruptured aneurysms, diagnostic imaging techniques, and medical imaging practices. The Angio suites' adaptability is a real asset because it allows for the execution of numerous medical operations. Angio suites offer a one-stop solution to patients, reducing the real trauma of the surgery by eliminating the need for patients to transition between various operating rooms.

Market Dynamics

Technological advancement in the CT Systems for Precision therapy in interventional oncology is expected to drive market growth.

Interventional radiology greatly benefits from combined angiography-CT (angio-CT) systems, which combine standard angiographic imaging with cross-sectional imaging. Although flat-panel angiography systems' cone-beam CT (CBCT) technology has long been used as an adjunct cross-sectional imaging tool during interventional procedures, the inherent benefits of angio-CT systems' superior soft-tissue imaging and contrast resolution, as well as their ease of operation, have reignited interest in their application to interventional oncology procedures. Angio-CT systems have emerged as a competitive alternative to standalone flat-panel angiographic systems with CBCT due to gains in pricing and usability brought on by improved workflow. Additionally, cross-sectional imaging from the CT scanner and fluoroscopic imaging from the angiography system are combined to more precisely plan oncologic interventions, combine multiple therapies in one location, and track intraprocedural treatment responses, minimizing complications and enhancing therapeutic outcomes. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

High costs associated with arranging angio suites, lacking skilled personnel who are proficient at using angio suites and increasing usage of reconditioned diagnostic imaging equipment, and significant radiation exposure risk are some of the factors the market is expected to hamper in the forecast period.

Industry Analysis

The angio suites market provides in-depth analysis of the market based on various industry factors such as porter's five forces, supply chain analysis, reimbursement scenario, product innovation, pricing analysis, etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. Heart disease and other chronic disease cases increased during the pandemic while the coronavirus was active. Because angio suites are the cutting-edge interventions used for precise and effective diagnosis that aid in visualizing the interior of human blood vessels, particularly the arteries, demand for them has skyrocketed. The abrupt and uncontrolled rise in COVID-19 cases led to a surge in patients with heart disease, raising the need for modern angio suites. The Centers for Disease Control and Prevention suggested postponing elective cardiac procedures, such as coronary angiography and percutaneous coronary intervention for stable coronary artery disease, to conserve resources, including personal protective equipment and hospital beds to care for COVID-19 patients. During the early stages of the COVID epidemic, it is predicted that STEMI activations in cardiac catheterization laboratories in the United States decreased by 38%, matching the 40% reduction seen in Spain.

Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Angioplasty segment is expected to hold the largest market share in angio suites market

The angioplasty segment is expected to dominate in 2021. The segment is beneficial because angioplasty is a procedure used to open coronary arteries that have become blocked due to coronary artery disease. Additionally, angioplasty has fewer scars, lessens post-operative side effects, a greater success rate, low invasion, and quick recovery. Additionally, as the burden of coronary heart disease rises, the demand for angioplasty increases since it can be used to enlarge blocked or restricted coronary arteries, keeping the patient safe. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global angio suites market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of cardiovascular diseases, rising investments in research & development, increasing high-quality medical facilities, including hospitals and laboratories, high level of awareness of healing difficulties and the availability of effective treatments and product launches and acquisitions by the key market players are some of the factors the market is expected to boost in the forecast period. For instance, In the United States, heart disease is the leading cause of death for both sexes and members of most racial and ethnic groups. Cardiovascular disease claims one life in the United States every 36 seconds. One in four deaths in the US is caused by heart disease, which affects about 659,000 people annually. Moreover, according to the American Heart Association, in 2019, at least 48 percent of adults in the United States suffer from cardiovascular disease.

Additionally, a subsidiary of renowned Massachusetts-based firm General Electric, GE Healthcare, announced the successful acquisition of Boston, Massachusetts-based imaging company "BK Medical" on December 21, 2021. The deal has been completed with a $1.45 billion payment from GE. Furthermore, the deal has helped GE Healthcare's ultrasound division grow. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the angio suites market are Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare, Carestream Health, Canon Medical Systems Corporation, Shimadzu Corp, 3D Systems, IMRIS.

3D Systems:

Overview:

A 3D printing service is provided by 3D Systems, a business with its main office in Rock Hill, South Carolina, which also designs, produces, and sells 3D printers, 3D printing supplies, and 3D scanners. The business produces master patterns for tooling, functional prototypes, production parts for direct digital manufacturing, and concept models for new product ideas. Input from computer-aided design and manufacturing software, 3D scanning, and 3D sculpting tools is used to produce real products utilizing proprietary techniques. Numerous industries, including aerospace, automotive, healthcare, dental, entertainment, and the creation of durable goods, employ the technologies and services provided by 3D Systems. The business provides a selection of 3D printers suitable for professional and industrial use, software, materials, and an online service for producing quick parts.

Product Portfolio:

Simulator-Angio-Mentor: ANGIO Mentor simulators provide multi-specialty hands-on practice of endovascular interventions in an extensive simulated clinical environment of a cath lab, interventional suite or a hybrid operating room. It provides a complete individual and team training solutions to learners of all levels.

The global angio suites market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancement in the CT Systems for Precision therapy in interventional oncology is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. High costs associated with arranging angio suites is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Single plane*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Biplane

8. By Equipment

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 8.1.2. Market Attractiveness Index, By Equipment Segment
  • 8.2. X-Ray Generator*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. C-Arm
  • 8.4. X-Ray Detector
  • 8.5. Operating Table
  • 8.6. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Angioplasty*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Therapeutic Stenting
  • 9.4. Obstruction Bypasses
  • 9.5. Intravascular Therapy
  • 9.6. Vertebroplasty
  • 9.7. Myelograms
  • 9.8. Arterial venous malformations surgery
  • 9.9. Coronary angiograms
  • 9.10. Others

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By Distribution Channel Segment
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Diagnostic Centers
  • 10.4. Cardiovascular catheterization laboratories
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Siemens Healthcare GmbH*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Koninklijke Philips N.V.
  • 13.3. GE Healthcare
  • 13.4. Carestream Health
  • 13.5. Canon Medical Systems Corporation
  • 13.6. Shimadzu Corp
  • 13.7. 3D Systems
  • 13.8. IMRIS

LIST NOT EXHAUSTIVE

14. Global Angio Suites Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us